Cargando…
Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer
This study aimed to explore the clinical and oncologic findings in patients with de novo metastatic prostate cancer (mPCa) and extraprostatic extension (EPE) on biopsy. We retrospectively evaluated data on 630 patients with de novo mPCa between January 2009 and December 2017 in the West China Hospit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406091/ https://www.ncbi.nlm.nih.gov/pubmed/31424026 http://dx.doi.org/10.4103/aja.aja_77_19 |
_version_ | 1783567375819341824 |
---|---|
author | Chen, Jun-Ru Zhao, Jin-Ge Zhu, Sha Zhang, Meng-Ni Chen, Ni Liu, Jian-Dong Sun, Guang-Xi Shen, Peng-Fei Zeng, Hao |
author_facet | Chen, Jun-Ru Zhao, Jin-Ge Zhu, Sha Zhang, Meng-Ni Chen, Ni Liu, Jian-Dong Sun, Guang-Xi Shen, Peng-Fei Zeng, Hao |
author_sort | Chen, Jun-Ru |
collection | PubMed |
description | This study aimed to explore the clinical and oncologic findings in patients with de novo metastatic prostate cancer (mPCa) and extraprostatic extension (EPE) on biopsy. We retrospectively evaluated data on 630 patients with de novo mPCa between January 2009 and December 2017 in the West China Hospital (Chengdu, China), including evaluating the relationships between EPE and other variables and the association of EPE with survival outcomes by the Chi-square test, Kaplan–Meier curves, and the Cox proportional-hazards model. EPE was found in 70/630 patients, making a prevalence of 11.1%. The presence of EPE on biopsy was associated with higher Gleason scores and higher incidence of neuroendocrine differentiation (NED), intraductal carcinoma of the prostate (IDC-P), and perineural invasion (PNI). Compared with those without EPE, patients with EPE had shorter castration-resistant prostate cancer-free survival (CFS; median: 14.1 vs 17.1 months, P = 0.015) and overall survival (OS; median: 43.7 vs 68.3 months, P = 0.032). According to multivariate analysis, EPE was not an independent predictor for survival. Subgroup analyses demonstrated that patients with favorable characteristics, including negative NED or IDC-P status, Eastern Cooperative Oncology Group (ECOG) score <2, and prostate-specific antigen (PSA) <50 ng ml(−1), had worse prognoses if EPE was detected. In patients with PSA <50 ng ml(−1), EPE was a negative independent predictor for OS (hazard ratio [HR]: 4.239, 95% confidence interval [CI]: 1.218–14.756, P = 0.023). EPE was strongly associated with other aggressive clinicopathological features and poorer CFS and OS. These data suggest that EPE may be an indicator of poor prognosis, particularly in patients, otherwise considered likely to have favorable survival outcomes. |
format | Online Article Text |
id | pubmed-7406091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-74060912020-08-17 Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer Chen, Jun-Ru Zhao, Jin-Ge Zhu, Sha Zhang, Meng-Ni Chen, Ni Liu, Jian-Dong Sun, Guang-Xi Shen, Peng-Fei Zeng, Hao Asian J Androl Original Article This study aimed to explore the clinical and oncologic findings in patients with de novo metastatic prostate cancer (mPCa) and extraprostatic extension (EPE) on biopsy. We retrospectively evaluated data on 630 patients with de novo mPCa between January 2009 and December 2017 in the West China Hospital (Chengdu, China), including evaluating the relationships between EPE and other variables and the association of EPE with survival outcomes by the Chi-square test, Kaplan–Meier curves, and the Cox proportional-hazards model. EPE was found in 70/630 patients, making a prevalence of 11.1%. The presence of EPE on biopsy was associated with higher Gleason scores and higher incidence of neuroendocrine differentiation (NED), intraductal carcinoma of the prostate (IDC-P), and perineural invasion (PNI). Compared with those without EPE, patients with EPE had shorter castration-resistant prostate cancer-free survival (CFS; median: 14.1 vs 17.1 months, P = 0.015) and overall survival (OS; median: 43.7 vs 68.3 months, P = 0.032). According to multivariate analysis, EPE was not an independent predictor for survival. Subgroup analyses demonstrated that patients with favorable characteristics, including negative NED or IDC-P status, Eastern Cooperative Oncology Group (ECOG) score <2, and prostate-specific antigen (PSA) <50 ng ml(−1), had worse prognoses if EPE was detected. In patients with PSA <50 ng ml(−1), EPE was a negative independent predictor for OS (hazard ratio [HR]: 4.239, 95% confidence interval [CI]: 1.218–14.756, P = 0.023). EPE was strongly associated with other aggressive clinicopathological features and poorer CFS and OS. These data suggest that EPE may be an indicator of poor prognosis, particularly in patients, otherwise considered likely to have favorable survival outcomes. Wolters Kluwer - Medknow 2019-08-16 /pmc/articles/PMC7406091/ /pubmed/31424026 http://dx.doi.org/10.4103/aja.aja_77_19 Text en Copyright: © The Author(s)(2019) http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Chen, Jun-Ru Zhao, Jin-Ge Zhu, Sha Zhang, Meng-Ni Chen, Ni Liu, Jian-Dong Sun, Guang-Xi Shen, Peng-Fei Zeng, Hao Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer |
title | Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer |
title_full | Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer |
title_fullStr | Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer |
title_full_unstemmed | Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer |
title_short | Clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer |
title_sort | clinical and oncologic findings of extraprostatic extension on needle biopsy in de novo metastatic prostate cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406091/ https://www.ncbi.nlm.nih.gov/pubmed/31424026 http://dx.doi.org/10.4103/aja.aja_77_19 |
work_keys_str_mv | AT chenjunru clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT zhaojinge clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT zhusha clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT zhangmengni clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT chenni clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT liujiandong clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT sunguangxi clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT shenpengfei clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer AT zenghao clinicalandoncologicfindingsofextraprostaticextensiononneedlebiopsyindenovometastaticprostatecancer |